Marker Therapeutics and ABB Robotics designed a robotic assistant prototype intended to be placed in a standard biosafety cabinet to collaborate with a human operator during mTAA-specific T cell ...
HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...
As thousands of attendees excitedly logged on to the opening session of ASGCT 2021, the 24th annual meeting of the American Society of Gene and Cell Therapy, they ...
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., (“CANbridge,”1228.HK) a leading China-based global biopharmaceutical company committed to the research, development and ...
Preclinical proof-of-concept data show the therapeutic potential of OTL-104 for NOD2 Crohn’s disease, a severe and treatment-refractory form of the disease In vivo data demonstrate the development of ...
-Factor to reveal novel mRNA-engineered immunosuppressive allogeneic cells. -Presentations will include latest data from Factor's library of novel ionizable lipids, including delivery of mRNA to T ...
Results of MCO therapy for multiple retinal diseases: Stargardt in human, and geographic atrophy in non-human primate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results